Abstract
Introduction: This study was destined to find out possible link between progression of Chronic kidney disease (CKD) and vitamin D level which is now very common worldwide specially in third world country like India where scarcity of research made it an emerging public health problem.
Materials and Methods: A total of 70 cases of CKD and 30 normal age, sex matched individuals as controls were taken after satisfying inclusion, exclusion criteria. Semi auto-analyzer to estimate serum creatinine and GFR estimation from the serum creatinine value was done by using Modification of diet in renal disease (MDRD) study equation. Specific reagent kit was used to estimate ACR. Estimation of serum Vitamin D (25-OH-D) was done by enzyme linked immunosorbent assay (ELISA). Correlation between serum Vitamin D level with GFR and ACR value were calculated to comment on role of Vitamin D level in progression of CKD. CKD was graded according to Kidney Disease Improving Global Outcomes (KDIGO) 2012 classification by GFR and ACR.
Results & Conclusion: 71.4% of CKD cases were found to be vitamin D deficient whereas control group showed only 30% prevalence (P<0.001 using Pearson Chi Square test).
Among the CKD cases there were significant deficiency of Vitamin D level with increasing CKD grade (49.9% in G3a, 53.83% in G3b, 68.42% in G4 and 83.48% in G5) (P<0.05 using Pearson Chi Square test).
Keywords: Vitamin D, Chronic kidney disease, GFR, ACR, KDOQI.
References
- National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-266.
- Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency : An Endocrine Society Clinical Practice Guideline.J Clin Endocrinol Metab. 2011;96:1911–30. [PubMed: 21646368]
- KDIGO Clinical practice guidelines for the diagnosis, evaluation, prevention and treatment of chronic kidney disease- mineral and bone disorder.Kidney Int Suppl.2009; 113:S1–130. [PubMed: 19644521]
- Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol 2008;3(5):1535–1541. [PubMed: 18525006]
- Al-Badr W, Martin KJ. Vitamin D and kidney disease. Clin J Am Soc Nephrol 2008;3(5):1555–1560. [PubMed: 18450926]
- Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-281. [PubMed:17634462]
- Jones G. Expanding role of vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1α-hydroxylase in the classical and nonclassical actions of 1α,25-dihydroxyvitamin D3. Seminars in Dialysis 2007;20(4):316–324. [PubMed: 17635821]
- Mehrotra R, Kermah D, Salusky I, Wolf M, Thadhani R, Chiu YW, Martins D, Adler S, Norris K. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 2009;76(9):977-83.
- Rostand SG, Warnock DG. Introduction to vitamin D symposium, March 14, 2008. Clin J Am Soc Nephrol 2008;3(5):1534. [PubMed: 18400968]
- Cheng S, Coyne D. Vitamin D and outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens 2007;16(2):77–82. [PubMed: 17293681]
- Li YC. Renoprotective effects of vitamin D analogs. Kidney Int. 2010 Jul;78(2):134-9.
- Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, et al. Global vitamin D status and determinants of hypovitaminosis D.Osteoporos Int.2009; 20:1807–20. [PubMed: 19543765]
- Matias P, Jorge C, Ferreira C, Borges M, Aires I, Amaral Y, et al. Cholecalciferol supplementation in hemodialysis patients : E0 ffects on mineral metabolism, inflammation, and cardiac dimension parameters.Clin J Am Soc Nephrol. 2010;5:905–11.[PubMed: 20203163]
- Kandula P, Dobre M, Schold JD, Schreiber MJ, Jr, Mehrotra R, Navaneethan SD. Vitamin D supplementation in chronic kidney disease: A0 systematic review and meta-analysis of observational studies and randomized controlled trials.Clin J Am Soc Nephrol. 2011;6:50–62.[PubMed: 20876671]
- Blair D, Byham-Gray L, Lewis E, McCaffrey S. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. J Ren Nutr. 2008;18:375–382.
- de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS: 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2007, 50(1):69–77.
- Melamed ML, Thadhani RI. Vitamin D Therapy in Chronic Kidney Disease and End Stage Renal Disease. Clin J Am Soc Nephrol.2012 Feb; 7(2): 358-365.
Corresponding Author
Dr Sujit Kumar Dey
Associate Professor, Dept. of Biochemistry, 4th Floor,
Academic Building, R. G. Kar Medical College, 1, Kshudiram Bose Sarani, Kolkata-004, India
Email: This email address is being protected from spambots. You need JavaScript enabled to view it., M: +919433725717
DOI: https://dx.doi.org/10.18535/jmscr/v6i5.19
